Looking to publish in Tumour Virus Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowTumour Virus Research is an open access journal affiliated with the World Society for Virology that publishes primary research and review articles on virally driven neoplasia, including molecular and cancer virology, tumour models, diagnostics, vaccines, therapies, clinical and epidemiological studies, and public awareness aspects. The journal particularly encourages mechanistic studies on how viruses drive malignant progression and welcomes cross-disciplinary contributions from virologists, immunologists, epidemiologists, clinicians, and public health researchers.
Looking to publish in Tumour Virus Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Tumour Virus Research accepts the following article types. Click on an article type to view submission instructions.
Original Research Articles
Reviews
Short Communications
Opinion Articles
Recent Publications
Ad-VT oncolytic adenovirus suppresses bladder cancer via cAMP-dependent AMPK-Raptor activation and G2/M arrest
Dapeng Li, Jing Lu, Ran Zhu, Xianyan Sun, Cuiling Zhang, Mingzhe Sun, Chengyuan Ma, Chao Shang, Xiao Li
HPV18E6 and CDK5 virus-host interaction is a prospective therapeutic target for HPV-positive cervical cancer
Chuanyun Xiao, Lixin Wang, Chichao Xia, Paul Kay Sheung Chan, Siaw Shi Boon
30-hydroxygambogic acid activates overlapping and independent apoptotic pathways in HPV positive and HPV negative oral cancer cells
Danelle Grubbs, Sonia Whang, Valeria Rodarte, Briza Martinez, Valeri Filippov, John Chen, Jaqueline Coats, Julia Unternaehrer, Isaac Kremsky, Brigitte Vazquez, Penelope J. Duerksen-Hughes
PRMT5–mediated symmetric dimethylation of SHBs at Arg169 stabilizes SHBs and promotes angiogenesis and tumor growth
Shuxiang Wu, Xiaozhen Chen, Yilin Huang, Fangrong Zhang, Xinjian Lin, Xu Lin
Susceptibility of naturally human papillomavirus type 16 major capsid protein L1 variants to vaccines and predictions of future evolutionary trends
Dongbo Yu, Jiao Wang, Ying Li, Hui Wang, Jieqiong Zhang, Mingming Wang, Haotian Li, Li Zhang, Na Zhu, Xuexin Lu, Shiwen Wang
Frequently asked questions
How long does it take to publish?
2 days from submission to first decision; 37 days from submission to decision after review; 65 days from submission to acceptance; 2 days from acceptance to online publication.
Reformat to Tumour Virus Research using Livewrite PremiumIs a cover letter required?
A cover letter should be included with submission. It should be short, focused, explain the study's aim and main findings, describe fit with the journal's aims and scope, emphasize novelty and broader implications, and acknowledge any invitation to submit. It should not include funding information, author declarations, or suggested or opposed reviewers.
Reformat to Tumour Virus Research using Livewrite PremiumWhat are the publication costs?
Article Publishing Charge: USD 3480 excluding taxes for all articles.
Reformat to Tumour Virus Research using Livewrite Premium